Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

FED × Topotecan × Lymphoid × Clear all

Phase

Status

Sponsor Class

OTHER 13 NIH 5 NETWORK 2 INDUSTRY 1 FED 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Plasma cell 1 Other hematologic neoplasm 1 Lymphoid 1

Conditions

Multiple Myeloma 1 Lymphoma, Non-Hodgkin 1 Lymphoma 1 Leukemia 1

Interventions

Clofarabine 2 zanubrutinib 1 venetoclax 1 talabostat 1 ibrutinib 1 acalabrutinib 1 Topotecan 1 Tablets 1 Rituximab 1 PT-100 dipeptide 1 Mitoxantrone 1 Midazolam 1 Ketamine 1 Imiquimod 1 Etoposide 1 Doxycycline 1 Biopsy, Large-Core Needle 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00100477 2013-09-25

Use of Topotecan in Patients With Refractory Acute Leukemia

VA Office of Research and Development

Phase 2 Completed

LymphoidOther hematologic neoplasmPlasma cell

Leukemia, Lymphoma, Lymphoma, Non-Hodgkin, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡